Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Public ClinicalTrials.gov record NCT06486454. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how different patient characteristics and procedural characteristics may affect histotripsy success at 36 hours post-histotripsy procedure. Sub-studies to the BOOMBOX: Master Study will investigate specific populations and/or clinical questions with more stringent enrollment criteria, standardized testing criteria, and/or follow-up schedule. Any participant enrolled in the BOOMBOX: Master Study that also qualifies for a sub-study may enroll in the sub-study in parallel; sub-studies will be described in separate sub-study protocols. The BOOMBOX: Master Study will collect information about participants before, during, and after the histotripsy treatment procedure. All participants will be followed per standard clinical follow-up based on each site's clinical practice for up to 5 years after the initial histotripsy procedure or until completion of their follow-up in a sub-study, whichever is longer.
Study identification
- NCT ID
- NCT06486454
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 5,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 13, 2024
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2031
- Last update posted
- Jul 7, 2026
2024 – 2031
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Providence St. Jude | Fullerton | California | 92835 | Recruiting |
| Mission Hospital | Mission Viejo | California | 92691 | Recruiting |
| Hoag | Newport Beach | California | 92663 | Recruiting |
| Sutter Bay Hospitals | San Francisco | California | 94107 | Recruiting |
| Providence Saint John's Health Center | Santa Monica | California | 90404 | Recruiting |
| AdventHealth Altamonte Springs | Altamonte Springs | Florida | 32701 | Withdrawn |
| AdventHealth Celebration | Celebration | Florida | 34747 | Recruiting |
| Lee Health Cancer Institute | Fort Myers | Florida | 33905 | Recruiting |
| Baptist Health Miami Cardiac & Vascular Institute | Miami | Florida | 33176 | Withdrawn |
| Northeast Georgia Medical Center | Gainesville | Georgia | 30501 | Recruiting |
| RUSH University Medical Center | Chicago | Illinois | 60612 | Recruiting |
| University of Chicago | Chicago | Illinois | 60637 | Recruiting |
| Willis Knighton Health | Shreveport | Louisiana | 71103 | Recruiting |
| Mass General Brigham | Boston | Massachusetts | 02115 | Recruiting |
| Henry Ford Health | Detroit | Michigan | 48202 | Recruiting |
| University of Michigan Health - West | Wyoming | Michigan | 49519 | Recruiting |
| Renown Regional Medical Center | Reno | Nevada | 89502 | Recruiting |
| NYU Langone Health | New York | New York | 10016 | Recruiting |
| Columbia University Irving Medical Center | New York | New York | 10032 | Recruiting |
| Weill Cornell Medicine | New York | New York | 10065 | Recruiting |
| University of Rochester Medical Center | Rochester | New York | 14642 | Recruiting |
| Novant Health | Winston-Salem | North Carolina | 27103 | Recruiting |
| Miami Valley Hospital South | Centerville | Ohio | 45459 | Recruiting |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | Recruiting |
| The Ohio State University | Columbus | Ohio | 43210 | Recruiting |
| Lehigh Valley Hospital | Allentown | Pennsylvania | 18103 | Recruiting |
| St. David's Medical Center | Austin | Texas | 78705 | Recruiting |
| Henrico Doctors' Hospital | Richmond | Virginia | 23229 | Recruiting |
| Swedish Medical Center | Seattle | Washington | 98122 | Terminated |
| University of Wisconsin | Madison | Wisconsin | 53792 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06486454, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06486454 live on ClinicalTrials.gov.